Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02559349 · ClinicalTrials.gov registry record
Gut Microbiota And Radiotherapy
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 10
- Enrollment target
NCT02559349 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 10 participants.
The verdict
NCT02559349 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
A pilot, single arm, single center study to determine the feasibility of obtaining stool samples from adult patients receiving SBRT to a lung tumor, if SBRT induces changes in the gut microbiota and to obtain preliminary data about possible correlation of baseline composition and changes in gut microbiota with tumor response, local control, and development of pneumonitis/other side effects.
Interventions
- OTHER Stool Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02559349
The ClinicalTrials.gov registry entry for NCT02559349 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stool Collection is the first listed.
NCT02559349 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02559349 about?
NCT02559349 is a clinical study titled "Gut Microbiota And Radiotherapy". A pilot, single arm, single center study to determine the feasibility of obtaining stool samples from adult patients receiving SBRT to a lung tumor, if SBRT induces changes in the gut microbiota and to obtain preliminary data about possible correlation of baseline composition and changes in gut micr...
What is the current status of trial NCT02559349?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2015-09. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02559349?
The interventions under investigation include: Stool Collection (OTHER).
Who is sponsoring clinical trial NCT02559349?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.